Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells.
- 23 July 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (15) , 8046-8050
- https://doi.org/10.1073/pnas.93.15.8046
Abstract
The Abeta peptide of Alzheimer disease is derived from the proteolytic processing of the amyloid precursor proteins (APP), which are considered type I transmembrane glycoproteins. Recently, however, soluble forms of full-length APP were also detected in several systems including chromaffin granules. In this report we used antisera specific for the cytoplasmic sequence of APP to show that primary bovine chromaffin cells secrete a soluble APP, termed solAPPcyt, of an apparent molecular mass of 130 kDa. This APP was oversecreted from Chinese hamster ovary cells transfected with a full-length APP cDNA indicating that solAPPcyt contained both the transmembrane and Abeta sequence. Deglycosylation of solAPPcyt showed that it contained both N- and O-linked sugars, suggesting that this APP was transported through the endoplasmic reticulum-Golgi pathway. Secretion of solAPPcyt from primary chromatin cells was temperature-, time-, and energy-dependent and was stimulated by cell depolarization in a Ca2+-dependent manner. Cholinergic receptor agonists, including acetylcholine, nicotine, or carbachol, stimulated the rapid secretion of solAPPcyt, a process that was inhibited by cholinergic antagonists. Stimulation of solAPPcyt secretion was paralleled by a stimulation of secretion in catecholamines and chromogranin A, indicating that secretion of solAPPcyt was mediated by chromaffin granule vesicles. Taken together, our results show that release of the potentially amyloidogenic solAPPcyt is an active cellular process mediated by both the constitutive and regulated pathways. solAPPcyt was also detected in human cerebrospinal fluid. Combined with the neuronal physiology of chromaffin cells, our data suggest that cholinergic agonists may stimulate the release of this APP in neuronal synapses where it may exert its biological functions. Moreover, vesicular or secreted solAPPcyt may serve as a soluble precursor of Abeta.Keywords
This publication has 40 references indexed in Scilit:
- Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor proteinNature, 1996
- The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathwayNature Medicine, 1995
- Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendritesJournal of Neuroscience Research, 1995
- Full‐Length and Truncated Alzheimer Amyloid Precursors in Chromaffin Granules: Solubilization of Membrane Amyloid Precursor Is Mediated by an Enzymatic MechanismJournal of Neurochemistry, 1995
- beta-Amyloid, protein processing and Alzheimer's disease.1995
- Involvement of amyloid as a central step in the development of Alzheimer's diseaseNeurobiology of Aging, 1994
- Solubilization of full-length amyloid precursor proteins from PC12 cell membranesJournal of Neuroscience Research, 1994
- Is amyloid causally involved in pathophysiology of alzheimer's disease?Neurobiology of Aging, 1994
- Chromaffin cells express Alzheimer amyloid precursor protein in the same manner as brain cellsNeuroscience Letters, 1994
- Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).Journal of Biological Chemistry, 1994